Canine-assisted ANxiety Reduction IN Emergency (CANINE)

September 20, 2018 updated by: Indiana University
The purpose of this study is to see if dogs can reduce the anxiety level of patients in the emergency department.

Study Overview

Status

Completed

Conditions

Detailed Description

Patients will score their pain, anxiety, and depression. A dog will then come into the patient's room for approximately 15 minutes after which the patient will score his/her pain, anxiety, and depression again.

Study Type

Observational

Enrollment (Actual)

80

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Indiana
      • Indianapolis, Indiana, United States, 46202
        • Indiana University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 90 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients enrolled from Emergency Department that are 18 or older with moderate or greater anxiety, per physician Gestalt.

Description

Inclusion Criteria:

  • Research staff will screen for inclusion criterion by asking the care providers if they agree with this statement, "I believe this patient is experiencing moderate or greater anxiety".

Exclusion Criteria:

  • Extreme intoxication, agitation that precludes conversation with the patient, fear of dogs, dog bite, allergy to dogs.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Dog
Patient sees therapy dog for 15 minutes, which is standard of care at this hospital.
No Dog
Patient receives standard of care

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Anxiety reduction from Scale
Time Frame: 30 mins
reduction in anxiety score (0-10). 0=balanced mood (least anxiety) 2= slight fear and worry 4=mild fear and worry 6= moderate worry, physical agitation 8=Feeling really bad, at the edge 10=out of control behavior, self-harm (worst anxiety)
30 mins

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain reduction from Wong Baker faces scale
Time Frame: 30 mins
reduction in pain score (0-10). 0=no hurt (least pain) 2= Hurts little bit 4= Hurts little more 6= Hurts even more 8= Hurts whole lot 10=out of control behavior, self-harm (hurts worst)
30 mins
Depression reduction from scale
Time Frame: 30 mins
reduction in depression score (0-10). 0= Balanced mood (least depressed) 2= Slightly depressed 4= Mildly depressed 6= Definite malaise 8= Feeling reall bad, at the edge 10=Despair, suicidal feelings (worst depressed)
30 mins

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 21, 2017

Primary Completion (Actual)

April 4, 2018

Study Completion (Actual)

April 4, 2018

Study Registration Dates

First Submitted

February 20, 2018

First Submitted That Met QC Criteria

March 13, 2018

First Posted (Actual)

March 20, 2018

Study Record Updates

Last Update Posted (Actual)

September 21, 2018

Last Update Submitted That Met QC Criteria

September 20, 2018

Last Verified

February 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • CANINE

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anxiety

3
Subscribe